NCT06598137 is a clinical trial of Ex vivo confocal laser microscopy in Benign Skin Tumor, sponsored by LMU Klinikum.

Who is sponsoring NCT06598137?

NCT06598137 is sponsored by LMU Klinikum.

What drugs are being tested in NCT06598137?

Interventions in NCT06598137: Ex vivo confocal laser microscopy.

What condition does NCT06598137 study?

NCT06598137 studies Benign Skin Tumor, Basal Cell Carcinoma, Melanoma, Squamous Cell Cancer.

Is NCT06598137 still recruiting?

NCT06598137 is currently active, enrolled. Last updated 25 September 2024.

Last reviewed 2024-09-25 · How we verify

NCT06598137

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study to Examine Lesions of the Skin Using Confocal Laser Microscopy

Active, enrolled Last updated 25 September 2024

What this trial tests

trial testing Ex vivo confocal laser microscopy in Benign Skin Tumor in 645 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 February 2024

Primary endpoint
31 December 2027

31 December 2028

Quick facts

Lead sponsor	LMU Klinikum
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	645
Start date	1 February 2024
Primary completion	31 December 2027
Estimated completion	31 December 2028
Sites	1 location across Germany

Drugs / interventions tested

Ex vivo confocal laser microscopy

Conditions studied

Benign Skin Tumor — all drugs for Benign Skin Tumor →
Basal Cell Carcinoma — all drugs for Basal Cell Carcinoma →
Melanoma — all drugs for Melanoma →
Squamous Cell Cancer — all drugs for Squamous Cell Cancer →

Sponsor

LMU Klinikum — full company profile →

Who can join

Eligibility, any sex, with Benign Skin Tumor or Basal Cell Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using ex-vivo confocal laser scanning microscopy, a reliable statement can be made about the extent, histological structure and possible significance of a skin change without having to send tissue samples for demanding and lengthy histological examinations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other LMU Klinikum trials

Trials by the same sponsor.

NCT07072676 — The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Train · NA · enrolling by invitation
NCT07159607 — Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR) · recruiting
NCT06600165 — Intraoperative Confocal Laser Scanning Microscopy With Use of AI for Optimized Surgical Excision of Basal Cell Carcinoma · recruiting
NCT07460531 — Assessment of Physical Activity and Cardiovascular Outcomes in Patients With Chronic Heart Failure · recruiting
NCT06605612 — Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06598137 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by LMU Klinikum
Last refreshed: 25 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06598137.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing